ID   JC-52
AC   CVCL_A1ER
SY   JFCR-Colorectal-52
DR   cancercelllines; CVCL_A1ER
DR   Cosmic; 2811066
DR   Wikidata; Q102114302
RX   PubMed=28179481;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Leu1342Ter (c.4025T>G); ClinVar=VCV000645602; Zygosity=Unspecified (PubMed=28179481).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser1343Phefs*10 (c.4028_4029delCT); ClinVar=VCV000824521; Zygosity=Unspecified (PubMed=28179481).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
RX   PubMed=28179481; DOI=10.1158/1535-7163.MCT-16-0578;
RA   Tanaka N., Mashima T., Mizutani A., Sato A., Aoyama A., Gong B.,
RA   Yoshida H., Muramatsu Y., Nakata K., Matsuura M., Katayama R.,
RA   Nagayama S., Fujita N., Sugimoto Y., Seimiya H.;
RT   "APC mutations as a potential biomarker for sensitivity to tankyrase
RT   inhibitors in colorectal cancer.";
RL   Mol. Cancer Ther. 16:752-762(2017).
//